Navigation Links
Downgraded Tier Positions and Step Therapy Restrictions Have Stalled Exforge's and Tekturna's Growth in The Hypertension Drug Market
Date:12/10/2008

MCO Pharmacy Directors Favor Individual, Generic Drugs Versus Newer Single-Pill Fixed Combination Brands, According to a New Report from HealthLeaders-InterStudy

NASHVILLE, Tenn., Dec. 10 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, finds that although Novartis' Exforge and Tekturna have slowly penetrated tier 2 levels of managed care organization (MCO) formularies over the last 12 months, their progress has stalled. Tekturna has stumbled from having 5.1 percent of U.S. patients accessing the drug at tier 2 in August 2008 to having only 3.9 percent of all patients with access at that same level in November 2008. According to the new Formulary Forum report entitled Formulary Advantages in Hypertension: Penetration of Advantaged Tiers by Novel Agents and Fixed-Dose Combinations, more surveyed MCO pharmacy directors indicate that they have downgraded Exforge's and Tekturna's tier position and/or added step therapy restrictions than indicated they had improved tier positioning of the drugs.

"The future reimbursement outlook for repackaging of individual hypertension agents is not that promising," according to Jason Labonte, Ph.D., vice president at HealthLeaders-InterStudy. "Forty-four to 67 percent of survey respondents favor use of individual (and often generic) drugs versus the newer single-pill, fixed-combination brands like Exforge and Daiichi Sankyo's Azor."

About Formulary Advantages in Hypertension: Penetration of Advantaged Tiers by Novel Agents and Fixed-Dose Combinations

The new Formulary Forum report is based on a survey of 50 pharmacy directors who control national, regional and state-level MCOs. Answers were segmented by type of plan to illustrate variances in strategy by size of plan. The easy-to-use PowerPoint format allows users
'/>"/>

SOURCE HealthLeaders-InterStudy
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. 11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions
2. More Than 1,600 Positions to be Filled at PharmaDiversity Job Board's eJobFair in September
3. Siemens Healthcare Executives Recognized With New Industry Leadership Positions
4. Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States
5. Debate Will Feature Clinton-Obama Positions on Health Care Followed by Straw Poll
6. New therapy prevents dangerous side effect for lymphoma patients
7. Intense chemotherapy wards off recurrence in half of mantle cell lymphoma patients after seven years
8. Statin Use Doesnt Inhibit Lymphoma Drug Therapy
9. Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkins Lymphoma
10. 33rd Annual Hutch Holiday Gala Raises Millions for Cancer Immunotherapy Research
11. Lenalidomide safe as single therapy for elderly CLL patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... 25 (HealthDay News) -- Animals make great companions for senior ... in the car are far more likely to crash than ... The new study included 2,000 licensed drivers aged 70 ... asked how often they drove with their pet in the ... the crash risk was twice as high as among those ...
(Date:5/25/2013)... Studies from Johns Hopkins University reveal a direct ... their inability to get adequate sleep. These same studies ... relieve many symptoms. , Johns Hopkins University School ... significantly associated with overall weight loss, especially belly fat. ... 6th, 2012, researchers monitored 77 participants who were diabetic ...
(Date:5/25/2013)... May 25, 2013 On May 20, 2013 ... do not wish to discuss or plan for their eventual ... FuneralFinancials.com released a Must-Do List to help people ... Financials recommends, “Creating a personal fact sheet.” , While not ... financial information and personal data. It may include a ...
(Date:5/25/2013)... By working diligently for months on ... of the 2012 Lamborghini Aventador into their well-built fitments ... in the list of vehicles lined by SizeItUp for ... set to thrill automobile lovers in the year 2013. ... looks, the 2012 Lamborghini Aventador comes with extraordinarily spacious ...
(Date:5/25/2013)... Many orthodontists have thought about moving their office ... is. Most people would naturally assume that the ... cloud service and support would own and maintain all ... they'd be wrong. Cloud providers lease space in ... that houses servers and related equipment to run cloud ...
Breaking Medicine News(10 mins):Health News:Seniors More Likely to Crash When Driving With Pet: Study 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2
... School of Public Health (HSPH) have found that children ... laws promoting smoke-free public places have significantly lower levels ... those living in counties with no smoke-free laws. ... with smoke-free laws had 39% lower prevalence of cotinine ...
... June 5 Patients undergoing treatment for melanoma that ... chemotherapy delivered directly into the liver,s blood vessels, according ... and Delcath Systems Inc., and led by James F. ... School of Medicine, and surgical oncologist with UPMC Cancer ...
... Studies show combo chemotherapy, new drug prolonged lives of ... News) -- Researchers report they prolonged survival for some ... the median survival is currently only about six months. ... called crizotinib shrank tumors in the majority of lung ...
... millions in hopes of protection against cancer and a host ... in reducing a patient,s risk of developing lung cancer - ... of an international Phase III clinical trial. Results from ... were presented today at the American Society of Clinical Oncology ...
... ... J. Brueck MD FACS, Fort Myers cosmetic surgeon, has applied stem cell therapy ... exist in a person’s fat. It can be harvested and spun down. It ... PRP is the result of the blood being spun down to create a ...
... ... the Savory Institute and the Africa Centre for Holistic Management are winning awards for their ... rivers back to life, increase food production and security and store carbon in ever deeper ... (PRWEB) ...
Cached Medicine News:Health News:Smoke-free air laws effective at protecting children from secondhand smoke 2Health News:New treatment method safe, effective for advanced melanoma patients 2Health News:Researchers Report Treatment Headway Against Lung Cancer 2Health News:Researchers Report Treatment Headway Against Lung Cancer 3Health News:Selenium shows no benefit in prevention of lung cancer 2Health News:Selenium shows no benefit in prevention of lung cancer 3Health News:Ft Myers Plastic Surgeon, Dr. Robert J. Brueck MD, Performs Facial Rejuvenation Using Innovative Stem Cell Therapy 2Health News:Ft Myers Plastic Surgeon, Dr. Robert J. Brueck MD, Performs Facial Rejuvenation Using Innovative Stem Cell Therapy 3Health News:Holistic Management and Allan Savory Win the 2010 Buckminster Fuller Award for Turning Deserts into Thriving Grasslands and Combating Climate Change. 2
(Date:5/24/2013)... 2013  BD (Becton, Dickinson and Company) (NYSE: ... that it will present at the Deutsche Bank 38 th ... at 10:40 a.m. (ET). A live webcast ... website at www.bd.com/investors and will be available for ... BD BD is a leading global medical technology ...
(Date:5/24/2013)... -- Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading ... Dr. Robert Grieve , the Company,s chairman ... , executive vice president and chief financial officer, will present ... held May 30, 2013 in New York City ... The Company,s presentation is scheduled to begin at 1:30 p.m. ...
(Date:5/24/2013)... , May 24, 2013  Sinovac Biotech Ltd. ... of biopharmaceutical products in China ... subsidiary company of Sinovac, obtained the Certificate of ... from the China State and Food Administration (CFDA) ... production plants, and its Changping filing and packaging ...
Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3
... DecisionView Inc., a leading provider of ... life sciences companies, today announced the release of ... flagship solution for patient enrollment planning, tracking and ... into site performance and cost projections, StudyOptimizer 4.3 ...
... 19, 2011 Reportlinker.com announces that ... available in its catalogue: ... http://www.reportlinker.com/p0358494/North-American-External-Defibrillator-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices ... state of the North American external ...
Cached Medicine Technology:DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting 2DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting 3North American External Defibrillator Market 2North American External Defibrillator Market 3North American External Defibrillator Market 4North American External Defibrillator Market 5North American External Defibrillator Market 6
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
... a layered design unique in the industry. ... prevent stray electrosurgical burns along the shaft ... or capacitive coupling; a well-documented patient safety ... AEM Instruments provides a neutral return path ...
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
Medicine Products: